Prosigna At a Glance : Clinical implications of the breast cancer intrinsic subtypes

(3:59)

[Chapter 3] Determine the theoretical density [g/cm³] of tantalum (MW-180.95 g/mol) 18.16 16.65 18…

(33)

Solutions to 13.1 Static Games (1.16-1.18) | Microeconomics Theory and Applications | Tutorial

(10:4)

Analysis of Lab Data: Linearisation of Exponential Data in Excel

(4:3)

Comparing MammaPrint to Oncotype Dx

(13:43)

Histology of the Breast

(4:2)

Oncotype DX for Breast Cancer

(2:2)

Brief Overview of Percepta and Envisia Classifiers

(2:3)

Prosigna Information Video for Healthcare Providers

(3:52)

Comparison of PAM50 intrinsic subtype profiles in matched primary and metastatic breast cancer

(29:36)

2022.09.24. SGR, Genomic Assessment with PAM50 subtypes in breast cancer(안성귀 교수님)

(51:1econd)

Comparative Studies of Prognostic Biomarkers

(56)

Prosigna Information Video for Breast Cancer Patients

(3:47)

Prosigna is powered by nCounter digital technology

(2:43)